Clinical Trials
171 trialsMULTISARC
Institut National de la Santé Et de la Recherche Médicale, France
MagMen-II
Vastra Gotaland Region
ANDROMEDA
Vastra Gotaland Region
FRI-STC
National Hepatology & Tropical Medicine Research Institute
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Vastra Gotaland Region
Lipiocis
ANRS, Emerging Infectious Diseases
ANVU
Queensland Centre for Gynaecological Cancer
Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment
Fujian Cancer Hospital
NELCER
Tata Memorial Hospital
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
The Affiliated People's Hospital of Ningbo University
FOCUS / KOV-04
National Cancer Center, Korea
KOV-HIPEC-02R
National Cancer Center, Korea
PARCER
Tata Memorial Hospital
CHOC-LATE
Tata Memorial Hospital
ENDO-3
Queensland Centre for Gynaecological Cancer
PICoC
The Royal Wolverhampton Hospitals NHS Trust
Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial
Henan Cancer Hospital
Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS
PAEC general hospital
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies
Anhui Provincial Hospital
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
Anhui Provincial Hospital
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
The Affiliated People's Hospital of Ningbo University
ETHOS
Norwegian Department of Health and Social Affairs
TREATT
NHS Blood and Transplant
LIBImAb
Azienda USL Reggio Emilia - IRCCS
PReCedeNT
Tata Memorial Hospital
Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
Tata Memorial Hospital
TARGET-02
Tata Memorial Hospital
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Fujian Cancer Hospital
ICRA
NHS Grampian
Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Henan Cancer Hospital
LEDANG
Hospital Sultanah Bahiyah
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
National Institute of Cancerología
MICHELE
National Institute of Cancerología
ARMADILLO
National Cancer Center, Japan
IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration
Fujian Cancer Hospital
Pre Operative Trastuzumab in Operable Breast Cancer
Tata Memorial Hospital
Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer
Tata Memorial Hospital
TNBC
Tata Memorial Hospital
PALERMO
University Hospital, Angers
Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
Region Västerbotten
SurVIC
All India Institute of Medical Sciences, Jodhpur
PATHOS
Velindre NHS Trust
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
Shanghai Gynecologic Oncology Group
Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer
Fujian Cancer Hospital
HELPER
National Cancer Center, Korea
EASTERN
National Cancer Center, Korea
SCRIPT-AML
Vastra Gotaland Region
SCANDIUM-III
Vastra Gotaland Region
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
Henan Cancer Hospital
Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital